baber/WOPTO huggingface dataset:
Patent SE-9800799-L (SE)
Inventor: BRADFORD LARRY
IPC: E02D29/14
Filed: 1998-03-12
Abstract: An improved access lid assembly is provided for a subsurface chamber used to service aircraft. A lift assembly is provided for elevating the lid upwardly from an opening in a surrounding mounting frame disposed atop the subsurface chamber while maintaining the lid in a horizontal disposition. A hinge assembly connects the lift assembly to the lid at a peripheral location thereon on the underside of the lid, without any connection to the peripheral edge of the lid. The hinge assembly allows the lid to rotate about a horizontal axis to an open position through an arc of at least ninety degrees. By avoiding any connection to the peripheral edges of the lid, an elastomeric, annular seal can be mounted to completely encircle the lid and provide a water-tight barrier about the access opening. The seal is mounted between the upper and lower surfaces of the lid within a groove, preferably with a dovetail connection, to securely grip and hold the seal upon the edge of the lid. Nevertheless, the use of an adhesive is avoided so that the seal can be easily removed and replaced when necessary. Also, the lift assembly is provided with a damper mechanism so as to protect the lift assembly from impacts and shocks that would otherwise result when the lid falls under the weight of gravity from an opened position to a horizontal disposition atop the access opening.
Patent SE-9801150-L (SE)
Inventor: ISAKSSON MIKAEL
IPC: H04L27/26
Filed: 1998-04-01
Abstract: Zipper is the time-synchronized frequency-division duplex implementation of discrete multi-tome (DMT) modulation. Two communicating Zipper modems transmit DMT symbols simultaneously with a common clock. When all transmitters are time synchronized, the near end cross-talk (NEXT) and near end echoes injected into the received signal are orthogonal to the desired signal. The present invention provides a telecommunications transmission system using zipper and having at least two VDSL systems. Each VDSL system comprises a pair of zipper modems communicating over a cable transmission path. The telecommunications transmission system handles zipper transmission transmitted over the common cable; at least partly mitigates NEXT; and permits transmissions in a first VDSL system which are asynchronous with transmissions in a second VDSL system.
Patent SE-9803176-L (SE)
Inventor: ISMAIL ZIAD
IPC: G08G1/127
Filed: 1998-09-18
Abstract: The invention refers to a device and a method for providing at least one service to at least one of a number of users who are connected to the device. The device includes a portable unit (1) for each user and at least one central unit (2, 2') having a computer (13, 13'). Furthermore, the device includes first means (15), which are arranged to enable communication from at least one producer (14) of said service to said central unit, second means (5) which are arranged to determine the geographic position of essentially each portable unit (1), and third means (3) which are arranged to enable communication in both directions between each portable unit and said central unit via a wireless communication network. The central unit (2, 2') is arranged to provide said service to the portable units fulfilling a certain criterion with respect to said geographic position.
Patent SE-9804165-L (SE)
Inventor: SINTORN TORKEL
IPC: F16F9/512
Filed: 1998-12-02
Abstract: A shock absorber is made with a bleed function and preferably a non-return valve function associated with the bleed function. The shock absorber has a cylinder (3) and, working in the latter in working medium and arranged on a piston rod (4), a piston arrangement. The latter comprises at least two first and second pistons (5, 6) arranged at a distance from one another on the piston rod. At least one piston (5) can, in connection with an end position, be introduced into a first space so as, depending on its position in or at the space, to bring about a modified or varied damping force relative to when the piston is located outside the space. The piston rod (4) is provided with an inner second space (15) which is arranged so as to contain said bleed and/or non-return valve function. Additionally or alternatively, the piston (6) working outside the first space is provided with a member performing a bleed function and with any associated non-return valve function. <IMAGE>
Patent FI-20080428-L (FI)
Inventor: AVENDANO CARLOS
IPC: G10L21/0232
Filed: 2008-07-04
Abstract: Systems and methods for utilizing level differences to attenuate noise and enhance speech are provided. In exemplary embodiments, energy estimates of acoustic signals, representing captured sound, are determined in order to determine a level difference. This level difference in combination with a noise estimate, based only on a primary acoustic signal, allow a filter estimate to be derived. In some embodiments, the derived filter estimate may be smoothed. The filter estimate is then applied to the acoustic signal from the primary acoustic signal to generate a speech estimate.
Patent NO-20021310-L (NO)
Title: Aminderivater
Inventor: EIERMANN VOLKER
IPC: C07D495/04
Filed: 2002-03-15
Abstract: Aminderivater med formel (I] R1 (l) samt deres fysiologisk akseptable salter og solvater, hvor R1, R2, R8, R9, R10, R11, Q, X, Y, Z, r og ringen A samt ringen C har de i krav l angitte betyd- ninger, utviser en fosfodiesterase V- inhibering og kan anvendes til behand- ling av sykdommer i hjerte-blodomløps- systemet og til behandling og/eller terapi av potensforstyrrelser.
Patent NO-20023607-L (NO)
Inventor: NIESCHLAG EBERHARD
IPC: A61K9/00
Filed: 2002-07-30
Abstract: A formulation for male contraception comprising a progestin possessing both estrogenic and androgenic properties is remarkably effective for spermatogenesis suppression in males. The progestin Norethisterone (NET), particularly its derivatives Norethisterone acetate and Norethisterone enanthate in sufficient doses induce oligozoospermia or azoospermia in males. Formulations further comprising an androgen, such as a testosterone derivative such as a testosterone ester, particularly testosterone undecanoate, are especially effective male contraceptive formulations.
Patent NO-20023629-L (NO)
Inventor: KAPLAN ANDREAS
IPC: C09D167/00
Filed: 2002-07-30
Abstract: The invention relates to a thermosetting coating mass, comprising a carboxyl functional polyester, and/or a carboxyl functional polyacrylate, a beta-hydroxyalkylamide, in which a portion of the hydroxyl groups are chemically blocked and/or fillers and/or heat stabilisers and/or triboadditives and/or further additives, such as, for example, dispersing and degassing agents.
Patent NO-20024468-L (NO)
Inventor: HOLDEN RICHARD H
IPC: H01P1/161
Filed: 2002-09-18
Abstract: A waveguide feed structure having a coaxial transmission line. A conductive, planar septum is disposed in, and along a diameter of, the transmission line. A feed port is electrically coupled to the transmission line. The septum has a rear portion disposed proximate the feed port, such rear portion of the septum extending between the inner conductor and the outer conductor. The feed port and the rear portion of the septum are arranged to establish an electric field in the transmission line between the inner conductor and the outer conductor with a component substantially TE11 mode along a direction perpendicular to the planar septum. A forward portion of the septum is asymmetrically disposed with respect to said diameter in order to provide a gap between the inner conductor and the outer conductor, such gap establishing an electric field component within the transmission line having a TE11 component along said diameter of the transmission line parallel to the plane of the septum. The septum has a pair of distal ends. One of the ends is separated from a proximate portion of the outer conductor and has a distance different from the separation between the other one of the pair of ends and a proximate portion of the outer conductor. In one embodiment, the first-mentioned distance increases along the transmission line from the rear portion of the septum to the forward portion of the septum. The distance is increased in steps to provide a 90 degree phase shift to energy propagating along the transmission line between a distal end of the septum and the outer conductor.
Patent NO-20025127-L (NO)
Inventor: SIMMONDS OLIVER
IPC: B66B5/22
Filed: 2002-10-25
Abstract: A braking device acts on a guide rail and consists of a housing that is arranged at an elevator car yoke and serves as a support for spring packets and/or for adjusting packets. The housing also serves as a support and guide for chock guide elements that in turn retain and guide brake chocks with brake linings. Pushrods engage at one end at the brake chocks, and at the other end are pivotably connected to an actuating fork. Upon braking of the elevator car, the actuating fork is moved at the pushrod end in the direction of the braking device. The guided brake chocks with the brake linings slide in the braking device. At the same time the brake linings are moved at the guide leg of the guide rail. The brake chocks are moved in the braking device and the spring and adjusting packets are stressed, whereby a braking force for stopping an elevator car or a counterweight is generated.
Patent NO-20030961-L (NO)
Inventor: DUDLEY ROBERT E
IPC: A61K31/565
Filed: 2003-02-28
Abstract: A pharmaceutical composition useful for treating hypogonadism is disclosed. The composition comprises an androgenic or anabolic steroid, a C1-C4 alcohol, a penetration enhancer such as isopropyl myristate, and water. Also disclosed is a method for treating hypogonadism utilizing the composition.
Patent NO-20041939-L (NO)
Inventor: OSHLACK BENJAMIN
IPC: A61K47/44
Filed: 2004-04-22
Abstract: (A) Controlled release oxycodone formulation for oral admin. to human patients, comprises (i) 10-40mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-60 ng/ml from a mean of 2-4.5 hrs.. After admin., and a mean min. plasma conc. of 3-30 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady state conditions. (ii) 10-160 mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin., and a mean min. plasma conc. from 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions. (B) Also claimed is a solid controlled release oral dosage form comprising (i) oxycodone or its salt in amt. of 10-160 mg; a controlled release matrix selected from hydrophilic hydrophobic polymers, digestible opt. substd. 8-50C hydrocarbons, and/or polyalkylene glycols; and a diluent; wherein the compsn. provides a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin, and mean min. plasma conc. of 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions; or (ii) an analgesically effective amt. of spheroids comprising oxycodone or its salt and either a spheronising agent or an acrylic polymer or copolymer, such that the total dosage of oxycodone in the dosage form is 10-160 mg; a film coating which controls the release of the oxycodone or its salt at a controlled rate in an aq. medium, wherein the compsn. provides an in vitro dissolution rate of the dosage form.
Patent NO-20044696-L (NO)
Inventor: BAXTER WILLIAM RONALD STUART
IPC: B41J11/00
Filed: 2004-10-29
Abstract: A method of printing an image on an object includes the steps of: providing an object having an exterior surface having a planar portion and a channel recessed from the planar portion; applying a first ground coat on the exterior surface; drying the first ground coat; and spraying droplets of ink on the dried ground coat to form an image, wherein the droplets are sprayed from an ink jet printhead that is maintained at a constant distance from the plane of the planar portion of the object.
Patent NO-20052458-L (NO)
Inventor: ESPINASSE PHILIPPE FRANCOIS
IPC: B63B22/02
Filed: 2005-05-23
Abstract: The installation is designed to transfer liquefied gas from a first surface reservoir (8) to a second surface reservoir (6) using a transfer line (28) designed to be connected to the reservoirs. The two reservoirs are spaced apart during the transfer and the transfer line is immersed in the water  The first and second reservoirs are more than 300 m apart, and preferably more than 1 marine mile, during the transfer. A first terminal (8) carries the first reservoir and a second terminal (22), in particular a loading buoy, is spaced from the first terminal so the transfer line extends between the two terminals. The second terminal is designed to connect the transfer line to a loading pipe (24) with connectors (25) to the second reservoir carried by a vessel. The transfer line has a main rigid section (32) which is horizontal in the layer of water where dynamic movements are reduced and flexible sections (40, 42) which are vertical and which connect the ends of the main section to the terminals and ensure continuity of liquid gas transport and absorb the dynamic movements. The main rigid section is in a layer of water where the maximum speed of the current is less than 1 m/s, preferably less than 0.5 m/s. The main section and the flexible sections of the transfer line have an internal transfer line and an external casing defining an annular space which extends the whole length of the transfer line and which is thermally insulated. The annular space is connected to means of evacuation so the space is held at a pressure below atmosphere, preferably below 100 mbar, more preferably below 30 mbar. The annular space is also placed under inert gas, in particular nitrogen. The installation includes means of verifying that the envelope and/or the pipe are leakproof. This is done using a detector of pressure variation in the annular space and delivers an alarm signal when the pressure variation is above a set value. Alternatively, a sensor detects the presence of one of the components of the liquefied gas in the annular space, in particular CH4, or detecting a drop in the amount of inert gas in the annular space. The internal pipe in the main section has a compensator (76, 78) at at least one end and the variation in length allowed by the compensator is at least the variation in length of the rigid part subject to the variation between the water temperature and the temperature of the liquefied gas. The main rigid section is suspended from a balancing body (94) which is designed to give it floatability or ballast. The main rigid section is suspended from the two terminals or anchored to the seabed by an anchor line. The main rigid section is a bundle of parallel pipes which include a pipe for returning the liquefied gas to the gaseous state, which passes from the second to the first reservoir.
Patent NO-20052553-L (NO)
Inventor: ORNING LARS
IPC: C07K16/44
Filed: 2005-05-26
Abstract: The present invention provides a specific binding partner for holoTC having a specificity for holoTC over apoTC of at least 40-fold and an assay method for assaying for holoTC in a sample, the method comprising contacting the sample with a specific binding partner for holoTC and detecting the resultant conjugates.
Patent NO-20053367-L (NO)
Title: Sigmareseptor-defisiente, mutante ikke-humane pattedyr og anvendelser derav.
Inventor: CASTANEDO DANIEL ZAMANILLO
IPC: C12N15/85
Filed: 2005-07-11
Abstract: Oppfinnelsen angår et sigmareseptordefisient, mutant, ikke-humant pattedyr og anvendelser derav. Genomet av det ikke-humane, mutante pattedyr, defisient i en endogen sigmareseptor, inneholder en mutasjon som omfatter en disrupsjon i et endogent sigmareseptorgen, karakterisert ved at nevnte gendisrupsjon fører til en mutant som mangler påvisbare nivåer av endogen sigmareseptor. Mutanten kan brukes som et kontrolldyr for in vivo tester, så vel som en kilde av celler som kan anvendes i in vitro tester. Mutanter defisiente i sigma-l-reseptoren kan anvendes som modeller for in vivo studie av forstyrrelser av sentralnervesystemet, hukommelsesendringer, stresstilstander og medikamentavhengighet, analgesiprosesser og nevrobeskyttelse. Mutanter defisiente i sigma-2-reseptoren kan anvendes for å studere diagnostiske eller terapeutiske verktøy for å bekjempe kreft og/eller degenerative prosesser og/eller designe forbindelser i stand til å forebygge, redusere eller lindre den sekundære patologi forbundet med administrasjon av nevroleptiske midler.
Patent NO-20060466-L (NO)
Title: Variable antibodies
Inventor: SAINT-REMY JEAN-MARIE
IPC: C07K16/36
Filed: 2006-01-30
Abstract: Foreliggende oppfinnelse angår inhibitoriske antistoffer mot faktor VIII med modifisert glykosylering, enten ved enzymatisk deglykosylering eller ved seterettet mutagenese. Nevnte antistoffer med modifisert glykosylering har lik affinitet for FVIII, men viser forskjellige inhiberingsegenskaper. Anvendelsen av en eller en blanding av nevnte antistoffer tillater modulering av inhiberingen av faktor VIII til nivåer mellom 40 og 95 %. Foreliggende oppfinnelse angår videre farmasøytiske preparater omfattende inhibitoriske antistoffer mot faktor VIII med modifisert glykosylering, kombinasjon av disse antistoffer og metoder for behandling av hemostatiske sykdommer ved anvendelse av nevnte antistoffer og antistoffblandinger.
Patent NO-20060550-L (NO)
Title: Ny terapeutisk formulering
Inventor: LODEN MARIE
IPC: A61K47/38
Filed: 2006-02-02
Abstract: Den foreliggende oppfinnelse vedrører et transkutant legemiddelleveringssystem omfattende dets fremstillingsmåte. Systemet omfatter et transkutant administrerbart fotosensitivt terapeutisk aktivt middel, fortrinnsvis et fotosensitivt ikke-steroid antiinflammatorisk middel, slik som ketoprofen; et geldannende middel; et hydrofilt løsningsmiddel; og et kosmetisk akseptabelt partikulært titandioksid. Bestanddelene i systemet og dets fremstilling følges på en måte som maksimaliserer levering og intradermale nivåer av intakt aktivt middel.
Patent NO-20060933-L (NO)
Title: Sko
Inventor: BIANCUCCI DEMETRIO
IPC: A43B3/16
Filed: 2006-02-27
Abstract: Sko som har en flik (7) leddforbundet med overdelen, slik at fliken kan bringes til en ikke-aktiv tilstand (1) i hvilken den ytre flaten på fliken (7) er nær overdelen (T) av skoen. Et beskyttelseselement (9) har en strimmel (90) som danner i det minste en første vinge (90a) og en andre vinge (90b), og inntar en utbrettet tilstand (D) som en følge av bestemmelse av den ikke-aktive tilstanden (1) til fliken (7), i hvilken strimmelen (90) omgir det bakre, øvre partiet av skoen (1) som rager opp over fliken (7), og den første vingen (90a) og den andre vingen (90b) omgir sidene av skoen for å overlappes over de motstående kanter (K) av det fremre, midtre partiet av overdelen (T), for å beskytte dette partiet mot eventuell vanninntrengning
Patent NO-20062086-L (NO)
Inventor: SAKAKURA YOSHINOBU
IPC: A47H13/04
Filed: 2006-05-09
Abstract: A curtain wave forming mechanism is constituted of curtain runners and a curtain hook attached to each curtain runner and hanging a curtain. The curtain hook is a separate body from a curtain tape and has a flat plate-like body section inserted into a hook insertion hole section of the curtain tape perpendicular to the length direction of a curtain rail, a foot section bent upward at the lower end central part of the body section and hooked to the hook insertion hole section, a shaft section extending from the upper central part of the body section, and a head section for insertion, formed on the head of the shaft section. A curtain runner has a body running in the curtain rail, a leg section hanging from the curtain rail, a hollow-cylindrical body supported at the leg section so as to be rotatable about the vertical axis of the leg section, and a bearing section for an insertion hook, supported at the hollow-cylindrical body.
Patent NO-20063060-L (NO)
Title: En elektronisk spillinnretning
Inventor: BENTLEY JOHN
IPC: A63F9/24
Filed: 2006-06-30
Abstract: En spillinnretning for å spille et spill med ett eller flere vinnernivåer, hvor innretningens vinnernivå har blitt forutbestemt, som innbefatter en elektronisk brikke programmert med dataprogram for spill av ett eller flere spill, hvor spillet har ett eller flere vinnernivåer og et trykt-kretskort for montering av brikken, hvor brikken har flere porter som kan forbindes til kretskortet og hvor portene kan bli forbundet med kretskortet i flere konfigurasjoner, idet konfigurasjonen av portenes forbindelse til kretskortet bestemmer spillets vinnernivå.
Patent NO-20065529-L (NO)
Title: Ventilasjonsanordning for telt.
Inventor: OSTBY KJELL
IPC: E04H15/16
Filed: 2006-11-30
Abstract: Den foreliggende oppfinnelsen vedrører et telt 2 med minst én teittopp 5 og en åpning i denne. En topphatt 1 er plassert over åpningen. En teltduk har en øvre begrensning eller kant 11 i en avstand under teittoppen 5. Topphatten 1 er tilpasset for plassering over åpningen i teittoppen 5 for helt eller delvis dekke denne Topphatten 1 er utformet av en duk med minst én spalte 3 med en første og en andre kant 6, 7. Spalten 3 strekker seg fra en nedre kant 8 av topphatten 1 og forløper opp mot en topp 4 på topphatten 1. Topphattens 1 nedre kant 8 og spaltens 3 ene kant 7 definerer et hjørne. Minst ett første trekkelement 14, 15 forløper fra en posisjon inne i teltet 2, til en plassering i nærheten av teltdukens øvre begrensning 11, gjennom en første innfesting 12 som tillater langsgående bevegelse av trekkelementet 14, 15. Trekkelementet innfestes i nærheten av hjørnet der topphattens 1 nedre kant 8 møter spaltens 3 første kant 7 og videre til en andre innfesting 13 som tillater langsgående bevegelse av trekkelementet 14, 15 og videre ned til en posisjon i teltet 2.
Patent NO-20070324-L (NO)
Inventor: DENG WEI
IPC: C07D261/02
Filed: 2007-01-17
Abstract: One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Patent NO-20071835-L (NO)
Inventor: GABETTA BRUNO
IPC: C07D305/04
Filed: 2007-04-10
Abstract: The invention relates to a process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel ( I )   
a synthon useful for the preparation of taxanes with antitumour activity, and intermediates for the preparation thereof.  The invention also discloses a process for the preparation of Docetaxel starting from said compound of formula (I).
Patent NO-20073054-L (NO)
Title: En fremgangsmate for fremstillingen av alfa-aryl-piperid-2-yl-acetamider og syrehydrolysen derav
Inventor: FRIGERIO MARCO
IPC: C07D211/08
Filed: 2007-06-15
Abstract: En fremgangsmåte for fremstillingen av ?-aryl-?-piperid-2-yl-acetamider med formel (I), hvori Ar er som definert i beskrivelsen, ved katalytisk reduksjon av ?-aryl-?-pyridin-2-yl-acetamider (II) med rodiumkatalysatorer. Acetamider med formel (II) kan deretter hydrolyseres til de tilsvarende aryleddiksyrene, f.eks. ritalinsyre, en direkte forløper av metylfenidat.